Gastrointestinal Cancers

Currently Available Clinical Trials from Georgetown Lombardi

Gastrointestinal Cancer
Bladder Cancer
Colorectal Cancer
Liver Cancer
Pancreatic Cancer
Rectal Cancer
Renal/Kidney Cancer

More clinical trials are available on NIH’s national clinical trial database and Lombardi’s clinical trials resources.

Ruesch Center for the Cure of Gastrointestinal Cancers

Fax: (202) 444-1229

John Marshall, MD
Director, Ruesch Center;
Division Chief, Hematology-Oncology, MedStar/Georgetown Hospital;
Associate Director for Clinical Research, Georgetown Lombardi

You will be redirected to our clinical partner, MedStar Georgetown University Hospital.

About the Cancer

Gastrointestinal (GI) cancers remain among the most fatal cancers. Advances in treatment have lagged well behind other disease priorities such as breast cancer because of a smaller pool of research funding and fewer survivors to carry the torch of advocacy.

The Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center and MedStar Georgetown University Hospital focuses on national efforts on curing this deadly set of diseases. Combining expertise in molecular medicine, translational research, and a patient-centered philosophy, the Ruesch Center realizes the dream of individualized curative therapies through research, care, and advocacy.

From the National Cancer Institute at the National Institutes of Health, find current information and resources on gastrointestinal cancers, incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials and research.

Learn more about pancreatic cancer and treatments available at MedStar Georgetown University Hospital.

What We Offer

Gastrointestinal cancers include: Anal Cancer, Colorectal (Colon) Cancer, Esophageal Cancer, Gallbladder Cancer, Gastrointestinal Carcinoid Tumors, Liver Cancer, Pancreatic Cancer, Small Intestine Cancer, Stomach (Gastric) Cancer.

Our Research

The Ruesch Center for the Cure of Gastrointestinal Cancers

Dramatic improvements in molecular biology have led to a better understanding of what makes cancers “tick.” New anti-cancer agents are being developed at an unprecedented pace. New technologies allow us to measure the many variables quickly and accurately. Improvements in bioinformatics allow us to analyze the resulting data sets. These advances form the foundation of personalized medicine, the only way forward in the quest to cure cancer.

Georgetown Lombardi’s world-renowned research faculty are discovering cancer risk factors, designing effective prevention strategies, and learning how to detect cancers earlier. They are developing and testing the cancer treatments of tomorrow — targeted therapies that will improve both survival and quality of life. They are making progress toward the ultimate goal: to eradicate cancer.

Gastrointestinal Cancer Research News from Lombardi